241 related articles for article (PubMed ID: 11462891)
1. Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies--the question of long-term palliation.
Bruha R; Petrtyl J; Kubecova M; Marecek Z; Dufek V; Urbanek P; Kodadova J; Chodounsky Z
Hepatogastroenterology; 2001; 48(39):631-7. PubMed ID: 11462891
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainage.
Born P; Rösch T; Brühl K; Sandschin W; Weigert N; Ott R; Frimberger E; Allescher HD; Hoffmann W; Neuhaus H; Classen M
Z Gastroenterol; 2000 Jun; 38(6):483-9. PubMed ID: 10923359
[TBL] [Abstract][Full Text] [Related]
3. Metallic stents in malignant biliary obstruction: prospective long-term clinical results.
Lee BH; Choe DH; Lee JH; Kim KH; Chin SY
AJR Am J Roentgenol; 1997 Mar; 168(3):741-5. PubMed ID: 9057527
[TBL] [Abstract][Full Text] [Related]
4. Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors.
Schleicher UM; Staatz G; Alzen G; Andreopoulos D
Strahlenther Onkol; 2002 Dec; 178(12):682-7. PubMed ID: 12491056
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic intraluminal brachytherapy and metal stent in malignant hilar biliary obstruction: a pilot study.
Singh V; Kapoor R; Solanki KK; Singh G; Verma GR; Sharma SC
Liver Int; 2007 Apr; 27(3):347-52. PubMed ID: 17355456
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of covered metallic stents in malignant biliary stenosis--prominent effectiveness in gallbladder carcinoma.
Kawamoto H; Ishida E; Okamoto Y; Okada H; Sakaguchi K; Nakagawa M; Sugihara T; Shiratori Y
Hepatogastroenterology; 2005; 52(65):1351-6. PubMed ID: 16201072
[TBL] [Abstract][Full Text] [Related]
7. [Metallic mesh endoprosthesis and intraluminal high dose rate 192Ir brachytherapy in the palliative treatment of malignant bile duct obstruction. Initial results].
Pakisch B; Klein GE; Stücklschweiger G; Lammer J; Poier E; Leitner H; Poschauko J; Hausegger KA; Hackl A
Rofo; 1992 Jun; 156(6):592-5. PubMed ID: 1377518
[TBL] [Abstract][Full Text] [Related]
8. Intraluminal implantation of radioactive stents for treatment of primary carcinomas of the peripancreatic-head region: a pilot study.
Liu Y; Lu Z; Zou DW; Jin ZD; Liu F; Li SD; Zhan XB; Zhang WJ; Wu RP; Yao YZ; Yang L; Li Z
Gastrointest Endosc; 2009 May; 69(6):1067-73. PubMed ID: 19243771
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for survival in patients with inoperable Klatskin tumors.
Arvanitakis M; Van Laethem JL; Pouzere S; Le Moine O; Deviere J
Hepatogastroenterology; 2006; 53(67):21-7. PubMed ID: 16506370
[TBL] [Abstract][Full Text] [Related]
10. Intraluminal high dose rate brachytherapy in the treatment of bile duct and gallbladder carcinomas.
Dvorák J; Jandík P; Melichar B; Jon B; Mergancová J; Zoul Z; Vacek Z; Petera J
Hepatogastroenterology; 2002; 49(46):916-7. PubMed ID: 12143240
[TBL] [Abstract][Full Text] [Related]
11. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A
Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized trial of Teflon versus polyethylene stents for distal malignant biliary obstruction.
van Berkel AM; Boland C; Redekop WK; Bergman JJ; Groen AK; Tytgat GN; Huibregtse K
Endoscopy; 1998 Oct; 30(8):681-6. PubMed ID: 9865556
[TBL] [Abstract][Full Text] [Related]
13. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
[TBL] [Abstract][Full Text] [Related]
14. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy.
Eschelman DJ; Shapiro MJ; Bonn J; Sullivan KL; Alden ME; Hovsepian DM; Gardiner GA
Radiology; 1996 Sep; 200(3):717-24. PubMed ID: 8756921
[TBL] [Abstract][Full Text] [Related]
15. Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study.
Suk KT; Kim JW; Kim HS; Baik SK; Oh SJ; Lee SJ; Kim HG; Lee DH; Won YH; Lee DK
Gastrointest Endosc; 2007 Oct; 66(4):798-803. PubMed ID: 17905025
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic strategies in hilar bile duct carcinoma (Klatskin's tumor)].
Lammert F; Busch N; Nguyen HN; Matern S
Dtsch Med Wochenschr; 1998 Oct; 123(40):1179-82. PubMed ID: 9793533
[No Abstract] [Full Text] [Related]
17. Microwave coagulation versus insertion of a second stent for occluded biliary metal stent.
Maetani I; Ukita T; Inoue H; Sato M; Igarashi Y; Sakai Y
Hepatogastroenterology; 2001; 48(41):1279-83. PubMed ID: 11677946
[TBL] [Abstract][Full Text] [Related]
18. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
[TBL] [Abstract][Full Text] [Related]
19. In-continuity hepatic resection for advanced hilar cholangiocarcinoma.
Zervos EE; Pearson H; Durkin AJ; Thometz D; Rosemurgy P; Kelley S; Rosemurgy AS
Am J Surg; 2004 Nov; 188(5):584-8. PubMed ID: 15546575
[TBL] [Abstract][Full Text] [Related]
20. Klatskin tumor--palliative therapy: the jury is still out or may be not yet in...
Geller A
Gastrointest Endosc; 2009 Jan; 69(1):63-5. PubMed ID: 19111687
[No Abstract] [Full Text] [Related]
[Next] [New Search]
